Back to Octagon Capital Advisors LP
Q2 2026 13F filing
Updated 27 days ago27 disclosed positions worth $1.1B
Portfolio value
$1.1B
Total holdings
27
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DNTH DIANTHUS THERAPEUTICS INC | $179.5M | 1.84M | 16.14% | — |
| 2 | D DFTX DEFINIUM THERAPEUTICS INC | $138.8M | 2.95M | 12.47% | — |
| 3 | A AAVXF ABIVAX SA | $132.3M | 993.0K | 11.89% | — |
| 4 | C COGT COGENT BIOSCIENCES INC | $90.9M | 2.35M | 8.17% | — |
| 5 | A ALMS ALUMIS INC | $79.7M | 2.83M | 7.16% | — |
| 6 | ? N/A ARRIVENT BIOPHARMA INC | $68.5M | 1.97M | 6.15% | — |
| 7 | T TSHA TAYSHA GENE THERAPIES INC | $66M | 9.69M | 5.93% | — |
| 8 | ? N/A BIOAGE LABS INC | $42.8M | 1.75M | 3.85% | — |
| 9 | M MIRM MIRUM PHARMACEUTICALS INC | $39.7M | 338.9K | 3.57% | — |
| 10 | K KYMR KYMERA THERAPEUTICS INC | $35.5M | 310.0K | 3.20% | — |
| 11 | A AKTS AKTIS ONCOLOGY INC | $31M | 960.8K | 2.78% | — |
| 12 | X XENE XENON PHARMACEUTICALS INC | $29.6M | 490.0K | 2.66% | — |
| 13 | ? N/A ERASCA INC | $23M | 1.25M | 2.07% | — |
| 14 | ? N/A PALISADE BIO INC | $21.5M | 10.28M | 1.93% | — |
| 15 | O OCFC OCULAR THERAPEUTIX INC | $20.4M | 2.08M | 1.83% | — |
| 16 | I IRON DISC MEDICINE INC | $19.7M | 270.0K | 1.77% | — |
| 17 | S SMMT SUMMIT THERAPEUTICS INC | $18.2M | 1.25M | 1.64% | — |
| 18 | P PHVS PHARVARIS N V | $15.8M | 456.7K | 1.42% | — |
| 19 | A ANL ADLAI NORTYE LTD | $10.7M | 934.7K | 0.97% | — |
| 20 | D DTIL PRECISION BIOSCIENCES INC | $10.6M | 1.35M | 0.95% | — |
| 21 | D DBVTF DBV TECHNOLOGIES S A | $9.4M | 574.2K | 0.85% | — |
| 22 | F FTH FAETH THERAPEUTICS INC | $9M | 361.0K | 0.81% | — |
| 23 | ? N/A GYRE THERAPEUTICS INC | $6.3M | 954.4K | 0.57% | — |
| 24 | T TRVI TREVI THERAPEUTICS INC | $5.9M | 315.0K | 0.53% | — |
| 25 | ? N/A UNICYCIVE THERAPEUTICS INC | $4.7M | 1.00M | 0.42% | — |
| 26 | C CNTX CONTEXT THERAPEUTICS INC | $1.7M | 3.05M | 0.15% | — |
| 27 | G GOSS GOSSAMER BIO INC | $1.3M | 7.75M | 0.11% | — |